-
Jan 18, 2023, 09:35
by
Seven-month study in an urban medical-surgical ICU highlights the impact of ActivePures proactive, continuous, disinfection technology on HAIs. Healthcare-Onset MRSA (HO-MRSA) bacteremia infections had a statistically significant 100% decrease (and in fact were eliminated during the trial period) when compared to the same time frame a year prior and the immediate six months prior.
Full story
-
Jan 18, 2023, 09:33
by
About Biopharma PEG
As a leading manufacturer of PEG derivatives, Biochempeg is dedicated to being your most reliable partner to provide a chemical synthesis and high-quality PEG linkers. We are committed to promoting the progress of your ADC discovery and development projects.
Contact us
Biopharma PEG Scientific Inc.
Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA
TEL: 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Website:https://www.biochempeg.com/
Full story
-
Jan 18, 2023, 01:00
by
User Not Found
Clinical Research News | A new study published in the Proceedings of the National Academy of Science demonstrates the potential for lab-grown retinal neurons to reestablish synaptic function and cure neurodegenerative eye disease, according to researchers from the University of Wisconsin–Madison.
Full story
-
Jan 17, 2023, 10:33
by
Full story
-
Jan 17, 2023, 10:32
by
Full story
-
Jan 16, 2023, 10:34
by
Full story
-
Jan 16, 2023, 10:33
by
Full story
-
Jan 16, 2023, 10:33
by
Full story
-
Jan 16, 2023, 10:32
by
Full story
-
Jan 13, 2023, 10:14
by
Pharmaceutical thermal protection specialist Tower Cold Chain is opening new office space in Tampines, Singapore, to support the company’s growth in the Asia Pacific region.
Full story
-
Jan 13, 2023, 01:00
by
User Not Found
Clinical Research News | A clinical trial’s path from initial design to completion is exceptionally complex. Poor patient recruitment and low retention rates complicate the clinical trial process, especially in studies for children with rare diseases. Thankfully, patient concierge services will offer immense insight into the unique support needs of individual pediatric patients and their families and increase the success rates for life-saving treatments.
Full story
-
Jan 11, 2023, 11:07
by
Full story
-
Jan 11, 2023, 11:06
by
Isohelix has announced that it has commenced engagement with the U.S. Food and Drug Administration to progress the full regulatory approval of the GeneFix® Saliva DNA Collectors into the USA.
Full story
-
Jan 11, 2023, 11:04
by
GenNext Technologies has announced the appointment of Dr. Lisa Jones as the company’s new Chief Science Officer.
Full story
-
Jan 11, 2023, 11:02
by
GenNext Technologies, Inc. has announced that Dr. John L. Grant has joined its Board of Directors (BOD).
Full story
-
Jan 11, 2023, 11:00
by
Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment
Full story
-
Jan 11, 2023, 01:00
by
User Not Found
Clinical Research News | Digital therapeutics are a natural fit with the decentralized clinical trial model and the COVID-19 pandemic has been a major driver of demand for both. The hybrid-designed PROSPER-FM trial is a good case in point. The devices being studied are a digital Acceptance and Commitment Therapy program and digital symptom tracker for adults with fibromyalgia and the single virtual site, run by Curavit, has been enrolling 10 times more patients than all other bricks-and-mortar sites starting at the same time.
Full story
-
Jan 10, 2023, 11:35
by
Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark.
London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.
Full story
-
Jan 10, 2023, 11:34
by
Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and amplification of Sanguine’s network of 60,000+ research-ready patient donor network.
Full story
-
Jan 10, 2023, 11:28
by
Full story